PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 11, 2026International Journal of Cardiology2 citationsOpen Access

Frequency of a very brief intervention to increase physical activity levels in cardiac rehabilitation attendees: The ‘Measure It!’ Multicentre randomised trial

NFNicole FreeneJSJess SeymourSMSteven M. McPhail

Key Result

Five physical activity measurements over 24 weeks did not significantly increase moderate-to-vigorous activity but yielded a clinically meaningful 447 daily step increase (p=0.075) in CHD patients.

Key Points

  • This study examines if the frequency of physical activity measurement impacts activity levels in cardiac rehabilitation attendees with coronary heart disease.
  • Two-arm multicentre randomized trial with concealed allocation and blinded assessments.
  • Participants included cardiac rehabilitation attendees randomized into 2-PAM or 5-PAM groups over 24 weeks.
  • Primary outcome was daily minutes of moderate-to-vigorous physical activity measured by accelerometry.
  • The 5-PAM group showed higher adjusted changes in MVPA and daily steps compared to the 2-PAM group, with a Cohen's f of 0.05 for MVPA and 0.14 for daily steps.
  • Daily steps increased by approximately 447 steps/day in the 5-PAM group, approaching clinical significance.
  • Quality-of-life improved significantly within groups over time (p<0.001).

Structured PICO

Does a higher frequency of physical activity measurement (5 vs 2 times over 24 weeks) increase daily minutes of moderate-to-vigorous physical activity in insufficiently active cardiac rehabilitation attendees with CHD?

P
Population
190 insufficiently active cardiac rehabilitation attendees with coronary heart disease (CHD)
I
Intervention
5 physical activity measurements (5-PAM) over 24-weeks using 'Measure It!' (self-report and step-tracker daily steps; <5min)
C
Comparator
2 physical activity measurements (2-PAM) over 24-weeks
O
Outcome
Daily minutes of moderate-to-vigorous physical activity (MVPA) measured by accelerometry at 24-weekssurrogate

A more frequent brief physical activity measurement intervention (5 vs 2 times over 24 weeks) did not significantly increase moderate-to-vigorous physical activity in cardiac rehabilitation attendees.

Abstract

BackgroundPhysical activity levels of cardiac rehabilitation attendees with coronary heart disease (CHD) are low.This study examined whether frequency of physical activity measurement (Measure It!; self-report and step-tracker daily steps; <5min) influenced ActiGraph accelerometermeasured physical activity in insufficiently active cardiac rehabilitation attendees with CHD. MethodsThis two-arm multicentre randomised trial with concealed allocation and blinded assessments included cardiac rehabilitation attendees (n=190) randomised to either 2 or 5-physical activity measurements (2-PAM or 5-PAM) over 24-weeks.The primary outcome was daily minutes of moderate-to-vigorous physical activity (MVPA; accelerometry).Secondary outcomes included daily steps (accelerometry), body-mass-index, waist circumference and quality-oflife (AQoL-6D). ResultsAdjusted point estimates of effect for change in MVPA (Cohen's f = 0.05) and daily steps (Cohen's f = 0.14) were higher at 24-weeks for the 5-PAM group than 2-PAM group but did not reach a-priori statistical significance at this small-medium effect size.For daily steps (difference-in-difference 447 steps/day, 95% CI: -44-to-938, p=0.075) the observed effect may be considered a clinically meaningful margin.Quality-of-life significantly improved within groups over time (p<0.001).Most participants received the Measure It! intervention as intended (2-PAM 2-measures: 76% (n=71/94); 5-PAM 4-measures: 92% (n=87/95). Conclusion

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Freene et al. (2026) studied this question. Five physical activity measurements over 24 weeks did not significantly increase moderate-to-vigorous activity but yielded a clinically meaningful 447 daily step increase (p=0.075) in CHD patients.

synapsesocial.com/papers/69d9e47378050d08c1b750achttps://doi.org/10.1016/j.ijcard.2026.134480
Ask AI
Helpful
Bookmark
Share
View Full Paper